Primary completion· ClinicalTrials.gov
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)
MM120 (LSD D-Tartrate) History and Updates
17 events · 2021 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
0
FDA Approvals
0
Label Revisions
17
Trial Milestones
0
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-05-25Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for MM120 (LSD D-Tartrate) since 2021, drawn from openFDA, ClinicalTrials.gov, and PubMed.
All published updates (2)
2025
- Results postedMM120 for ADHD: Phase 2 Trial Shows No Significant Improvement vs. Placebo· Apr 13, 2025
- Results postedMM120 (LSD D-Tartrate) Phase 2 Trial Shows Dose-Response for Anxiety Symptoms· Mar 20, 2025
Upcoming & expected milestones
Primary completion· ClinicalTrials.gov
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Past events
2026
Primary completion· ClinicalTrials.gov
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
2025
Trial registered· ClinicalTrials.gov
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)
Trial started· ClinicalTrials.gov
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)
Results posted· ClinicalTrials.gov
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Results posted· ClinicalTrials.gov
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Trial registered· ClinicalTrials.gov
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Trial started· ClinicalTrials.gov
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
2024
Trial registered· ClinicalTrials.gov
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Trial started· ClinicalTrials.gov
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
2023
Primary completion· ClinicalTrials.gov
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Primary completion· ClinicalTrials.gov
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
2022
Trial started· ClinicalTrials.gov
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Trial registered· ClinicalTrials.gov
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Trial registered· ClinicalTrials.gov
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
2021
Trial started· ClinicalTrials.gov
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.